137 related articles for article (PubMed ID: 37721536)
1. Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis.
Pradhan AK; Modi J; Maji S; Kumar A; Bhoopathi P; Mannangatti P; Guo C; Afosah DK; Mochel MC; Mukhopadhyay ND; Kirkwood JM; Wang XY; Desai UR; Sarkar D; Emdad L; Das SK; Fisher PB
Mol Cancer Ther; 2023 Oct; 22(10):1115-1127. PubMed ID: 37721536
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/Syntenin.
Kegelman TP; Wu B; Das SK; Talukdar S; Beckta JM; Hu B; Emdad L; Valerie K; Sarkar D; Furnari FB; Cavenee WK; Wei J; Purves A; De SK; Pellecchia M; Fisher PB
Proc Natl Acad Sci U S A; 2017 Jan; 114(2):370-375. PubMed ID: 28011764
[TBL] [Abstract][Full Text] [Related]
3. Src kinase activation is mandatory for MDA-9/syntenin-mediated activation of nuclear factor-kappaB.
Boukerche H; Aissaoui H; Prévost C; Hirbec H; Das SK; Su ZZ; Sarkar D; Fisher PB
Oncogene; 2010 May; 29(21):3054-66. PubMed ID: 20228839
[TBL] [Abstract][Full Text] [Related]
4. MDA-9/syntenin is essential for factor VIIa-induced signaling, migration, and metastasis in melanoma cells.
Aissaoui H; Prévost C; Boucharaba A; Sanhadji K; Bordet JC; Négrier C; Boukerche H
J Biol Chem; 2015 Feb; 290(6):3333-48. PubMed ID: 25505176
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological inhibition of MDA-9/Syntenin blocks breast cancer metastasis through suppression of IL-1β.
Pradhan AK; Maji S; Bhoopathi P; Talukdar S; Mannangatti P; Guo C; Wang XY; Cartagena LC; Idowu M; Landry JW; Sarkar D; Emdad L; Cavenee WK; Das SK; Fisher PB
Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34016751
[TBL] [Abstract][Full Text] [Related]
6. Syntenin-syndecan binding requires syndecan-synteny and the co-operation of both PDZ domains of syntenin.
Grootjans JJ; Reekmans G; Ceulemans H; David G
J Biol Chem; 2000 Jun; 275(26):19933-41. PubMed ID: 10770943
[TBL] [Abstract][Full Text] [Related]
7. Suppression of Prostate Cancer Pathogenesis Using an MDA-9/Syntenin (SDCBP) PDZ1 Small-Molecule Inhibitor.
Das SK; Kegelman TP; Pradhan AK; Shen XN; Bhoopathi P; Talukdar S; Maji S; Sarkar D; Emdad L; Fisher PB
Mol Cancer Ther; 2019 Nov; 18(11):1997-2007. PubMed ID: 31345950
[TBL] [Abstract][Full Text] [Related]
8. mda-9/Syntenin regulates the metastatic phenotype in human melanoma cells by activating nuclear factor-kappaB.
Boukerche H; Su ZZ; Emdad L; Sarkar D; Fisher PB
Cancer Res; 2007 Feb; 67(4):1812-22. PubMed ID: 17308124
[TBL] [Abstract][Full Text] [Related]
9. mda-9/Syntenin: a positive regulator of melanoma metastasis.
Boukerche H; Su ZZ; Emdad L; Baril P; Balme B; Thomas L; Randolph A; Valerie K; Sarkar D; Fisher PB
Cancer Res; 2005 Dec; 65(23):10901-11. PubMed ID: 16322237
[TBL] [Abstract][Full Text] [Related]
10. Syntenin: a novel PDZ domain-containing scaffolding protein associated with human melanoma metastasis.
Yang JB; McCarthy JB
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Apr; 32(2):204-12. PubMed ID: 17478924
[TBL] [Abstract][Full Text] [Related]
11. mda-9/Syntenin promotes metastasis in human melanoma cells by activating c-Src.
Boukerche H; Su ZZ; Prévot C; Sarkar D; Fisher PB
Proc Natl Acad Sci U S A; 2008 Oct; 105(41):15914-9. PubMed ID: 18832467
[TBL] [Abstract][Full Text] [Related]
12. A PDZ Protein MDA-9/Syntenin: As a Target for Cancer Therapy.
Yu Y; Li S; Wang K; Wan X
Comput Struct Biotechnol J; 2019; 17():136-141. PubMed ID: 30766662
[TBL] [Abstract][Full Text] [Related]
13. Activation of the integrin effector kinase focal adhesion kinase in cancer cells is regulated by crosstalk between protein kinase Calpha and the PDZ adapter protein mda-9/Syntenin.
Hwangbo C; Kim J; Lee JJ; Lee JH
Cancer Res; 2010 Feb; 70(4):1645-55. PubMed ID: 20145126
[TBL] [Abstract][Full Text] [Related]
14. Targeting tumor invasion: the roles of MDA-9/Syntenin.
Kegelman TP; Das SK; Emdad L; Hu B; Menezes ME; Bhoopathi P; Wang XY; Pellecchia M; Sarkar D; Fisher PB
Expert Opin Ther Targets; 2015 Jan; 19(1):97-112. PubMed ID: 25219541
[TBL] [Abstract][Full Text] [Related]
15. Syntenin-targeted peptide blocker inhibits progression of cancer cells.
Liu J; Qu J; Zhou W; Huang Y; Jia L; Huang X; Qian Z; Xia J; Yu Y
Eur J Med Chem; 2018 Jun; 154():354-366. PubMed ID: 29857221
[TBL] [Abstract][Full Text] [Related]
16. MDA-9/syntenin: a positive gatekeeper of melanoma metastasis.
Das SK; Bhutia SK; Kegelman TP; Peachy L; Oyesanya RA; Dasgupta S; Sokhi UK; Azab B; Dash R; Quinn BA; Kim K; Barral PM; Su ZZ; Boukerche H; Sarkar D; Fisher PB
Front Biosci (Landmark Ed); 2012 Jan; 17(1):1-15. PubMed ID: 22201728
[TBL] [Abstract][Full Text] [Related]
17. The MDA-9/Syntenin/IGF1R/STAT3 Axis Directs Prostate Cancer Invasion.
Das SK; Pradhan AK; Bhoopathi P; Talukdar S; Shen XN; Sarkar D; Emdad L; Fisher PB
Cancer Res; 2018 Jun; 78(11):2852-2863. PubMed ID: 29572229
[TBL] [Abstract][Full Text] [Related]
18. Fragment-based drug design targeting syntenin PDZ2 domain involved in exosomal release and tumour spread.
Garcia M; Hoffer L; Leblanc R; Benmansour F; Feracci M; Derviaux C; Egea-Jimenez AL; Roche P; Zimmermann P; Morelli X; Barral K
Eur J Med Chem; 2021 Nov; 223():113601. PubMed ID: 34153575
[TBL] [Abstract][Full Text] [Related]
19. MDA-9/Syntenin-Slug transcriptional complex promote epithelial-mesenchymal transition and invasion/metastasis in lung adenocarcinoma.
Wang LK; Pan SH; Chang YL; Hung PF; Kao SH; Wang WL; Lin CW; Yang SC; Liang CH; Wu CT; Hsiao TH; Hong TM; Yang PC
Oncotarget; 2016 Jan; 7(1):386-401. PubMed ID: 26561205
[TBL] [Abstract][Full Text] [Related]
20. Knockout of MDA-9/Syntenin (SDCBP) expression in the microenvironment dampens tumor-supporting inflammation and inhibits melanoma metastasis.
Das SK; Guo C; Pradhan AK; Bhoopathi P; Talukdar S; Shen XN; Emdad L; Subler MA; Windle JJ; Sarkar D; Wang XY; Fisher PB
Oncotarget; 2016 Jul; 7(30):46848-46861. PubMed ID: 27341128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
